Business Description
Epizyme Inc
NAICS : 325412
SIC : 2834
ISIN : US29428V1044
Share Class Description:
EPZM: Ordinary SharesDescription
Epizyme Inc is a clinical-stage biopharmaceutical company that is committed to rewriting treatment for cancer and other serious diseases through discovering, developing, and commercializing novel epigenetic medicines. Its product candidates include one approved product, TAZVERIK (tazemetostat), an inhibitor of the EZH2. The company is also developing additional programs, such as pinometostat, an intravenously administered small molecule inhibitor of DOT1L for the treatment of acute leukemias and PRMT5 inhibitor.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.61 | |||||
| Equity-to-Asset | -0.08 | |||||
| Debt-to-Equity | -11.72 | |||||
| Debt-to-EBITDA | -1.33 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -7.94 | |||||
| Beneish M-Score | -2.09 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.5 | |||||
| 3-Year EBITDA Growth Rate | -8.2 | |||||
| 3-Year EPS without NRI Growth Rate | -12.5 | |||||
| 3-Year FCF Growth Rate | -9.3 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -8.59 | |||||
| 12-1 Month Momentum % | -72.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.35 | |||||
| Quick Ratio | 5.19 | |||||
| Cash Ratio | 4.13 | |||||
| Days Inventory | 89.88 | |||||
| Days Sales Outstanding | 47.01 | |||||
| Days Payable | 227.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.2 | |||||
| Shareholder Yield % | -16.3 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 75.57 | |||||
| Operating Margin % | -370.04 | |||||
| Net Margin % | -391.89 | |||||
| FCF Margin % | -394.05 | |||||
| ROE % | -1953.82 | |||||
| ROA % | -67 | |||||
| ROIC % | -201.41 | |||||
| ROC (Joel Greenblatt) % | -804.69 | |||||
| ROCE % | -68.23 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.8 | |||||
| EV-to-EBIT | -1.86 | |||||
| EV-to-EBITDA | -1.91 | |||||
| EV-to-Revenue | 6.43 | |||||
| EV-to-Forward-Revenue | 7.89 | |||||
| EV-to-FCF | -1.63 | |||||
| Earnings Yield (Greenblatt) % | -53.76 | |||||
| FCF Yield % | -109.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:EPZM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Epizyme Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 53.008 | ||
| EPS (TTM) ($) | -1.72 | ||
| Beta | 0 | ||
| Volatility % | 278.24 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.021429 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | -72.51 | ||
| 52-Week Range ($) | 0.41095 - 5.8 | ||
| Shares Outstanding (Mil) | 168.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Epizyme Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Epizyme Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Epizyme Inc Frequently Asked Questions
What is Epizyme Inc(EPZM)'s stock price today?
The current price of EPZM is $1.47. The 52 week high of EPZM is $5.80 and 52 week low is $0.41.
When is next earnings date of Epizyme Inc(EPZM)?
The next earnings date of Epizyme Inc(EPZM) is 2024-08-09 Est..
Does Epizyme Inc(EPZM) pay dividends? If so, how much?
Epizyme Inc(EPZM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers